Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease
Phase II Study of the Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease
Sponsor: National Eye Institute (NEI)
A PHASE2 clinical study on Corneal Epithelial Disorders and Persistent Corneal Epithelial Defect, this trial is actively recruiting participants. The trial is conducted by National Eye Institute (NEI) and has accumulated 4 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Feb 2026 — Present [monthly]
Recruiting PHASE2
-
Nov 2025 — Feb 2026 [monthly]
Recruiting PHASE2
Status: Withheld → Recruiting · Phase: None → PHASE2
-
Jun 2025 — Nov 2025 [monthly]
Withheld
-
May 2025 — Jun 2025 [monthly]
Withheld
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Eye Institute (NEI)
- National Institutes of Health (NIH)
- University of Illinois at Chicago
For direct contact, visit the study record on ClinicalTrials.gov .